Anúncio
Anúncio

WGS

WGS logo

GeneDx Holdings Corp. Class A Common Stock

135.52
USD
Patrocinado
-1.95
-1.42%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

137.72

+2.21
+1.63%

Relatórios de Lucros WGS

Rácio de surpresa positiva

WGS separação 12 de 17 últimas estimativas.

71%

Próximo Relatório

Data do Próximo Relatório
16 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$121.58M
/
$0.10
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+4.14%
/
-79.59%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+27.12%
/
-83.87%

GeneDx Holdings Corp. Class A Common Stock earnings per share and revenue

On 28 de out. de 2025, WGS reported earnings of 0.49 USD per share (EPS) for Q3 25, beating the estimate of 0.42 USD, resulting in a 14.73% surprise. Revenue reached 116.74 milhão, compared to an expected 105.72 milhão, with a 10.43% difference. The market reacted with a +5.21% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analistas forecast an EPS of 0.10 USD, with revenue projected to reach 121.58 milhão USD, implying an diminuir of -79.59% EPS, and aumentar of 4.14% in Revenue from the last quarter.
FAQ
For Q3 2025, GeneDx Holdings Corp. Class A Common Stock reported EPS of $0.49, beating estimates by 14.73%, and revenue of $116.74M, 10.43% above expectations.
The stock price moved up 5.21%, changed from $130.66 before the earnings release to $137.47 the day after.
The next earning report is scheduled for 16 de fev. de 2026.
Based on 10 analistas, GeneDx Holdings Corp. Class A Common Stock is expected to report EPS of $0.10 and revenue of $121.58M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio